Posts Tagged: bio


The U.S. Government’s Position in ACLU v. Myriad Genetics: Observations on a ‘Waste of Time and Space’

So maybe the Federal Circuit won’t find “preemption” to be useful in deciding this appeal; we’ll know soon enough. I, for one, can’t make …
By Hans Sauer
8 years ago 6

BIO Hails House Passage of FDA Safety and Innovation Act

It will enhance the development and review of innovative new therapies through increased transparency and scientific dialogue, advancements in regulatory science and strengthened post-market review. It will …
By Jim Greenwood
8 years ago 0

University Licensing and Biotech IPRs Good for the Economy

Earlier in the week BIO also unveiled another report it commissioned and which was authored by Lori Pressman, David Roessner, Jennifer Bond, Sumiye Okubo, and Mark Planting. …
By Gene Quinn
8 years ago 1

BIO Lauds Senate Passage of User Fee Package

The inclusion of an enhanced Accelerated Approval pathway, crafted by Senator Kay Hagan (D-NC), will help expedite the development of modern, targeted, and personalized therapies for patients …
By Gene Quinn
8 years ago 0

Insiders React to Supreme Court Prometheus Decision

Just over three weeks ago the United States Supreme Court issued a decision in Mayo Collaborative Services v. Prometheus Laboratories, which sent much of the patent world …
By Gene Quinn
8 years ago 25

Industry Urges Congress to Continue Renewable Fuel Standard

While many people believe that alternative energy is at least several decades away, what is clear is that if we do not set out about making that …
By Gene Quinn
9 years ago 1

House Patent Reform Bill is in Need of Reform, BIO to Oppose

BIO has consistently praised House Judiciary Committee Chairman Lamar Smith (R-TX) for his introduction of a comprehensive patent reform bill similar to the bill adopted by the …
By Jim Greenwood
9 years ago 4

Ethical Issues: Staying in the Frying Pan and out of the Fire

In the situation where there is a joint research collaboration everything is fine, people are happy and hope springs eternal right up until that moment when everything …
By Gene Quinn
9 years ago 1

A Landmark Case: The Aftermath of Myriad Genetics

Richard M. Marsh, Executive Vice President and General Counsel for Myriad Genetics is on the panel. He started off his presentation explaining that he really wants to …
By Gene Quinn
9 years ago 18

Stanford v. Roche: An Academic/Industry Collaboration Gone Wrong

This morning the first panel discussion is focusing on Stanford v. Roche, titled Who's Rights Are They Anyway? The first speaker, Maggie Shafmaster, Ph.D., Vice President …
By Gene Quinn
9 years ago 3

BIO Expresses Some Concern with House Patent Reform

BIO also is concerned about the inclusion of broader prior user rights in the House bill, and believes that this issue, coupled with the harmful inter partes …
By Jim Greenwood
9 years ago 3

Amici Support i4i at Supreme Court in Microsoft Patent Case

What becomes clear in reading these briefs (and the excerpts below) is that despite what you might have heard to the contrary the Supreme Court has already …
By Gene Quinn
9 years ago 4

BIO Opens Nominations For 2011 Biotech Humanitarian Award

The Humanitarian Award honors work that aims to reduce human suffering significantly or enhance the human experience in a way that has a clear and direct benefit …
By Press Releases
9 years ago 0

Erik Iverson: Gates Foundation Interview Part 2

As a prelude to his presentation at BIO Mr. Iverson agreed to go on the record with me. Part 1 of my interview with Mr. Iverson was published …
By Gene Quinn
9 years ago 5

Interview: Erik Iverson of the Bill & Melinda Gates Foundation

Erik Iverson is Associate General Counsel with the Bill & Melinda Gates Foundation, working exclusively with Foundation's Global Health initiate. Mr. Iverson works with grantees in the development …
By Gene Quinn
9 years ago 10